心房颤动伴长R-R间期与心脏性猝死的关系

近年来,随着对心房颤动(房颤)临床观察研究的不断深入,发现一种较为普通存在的现象,即房颤患者其动态心电监护多见有明显R-R间期延长,同时有研究表明房颤伴长R-R间期与心脏性猝死有一定的相关性,并且临床医生为避免这一猝死现象往往选择了心脏起搏治疗来预防猝死,现将房颤伴长R-R间期与心脏性猝死的关系做一综述.     

Prolonged Atrium Electromechanical Interval Is Associated with Stroke in Patients with Atrial Fibrillation After Catheter Ablation

Electromechanical Interval and Strokes After Ablations of AF . Introduction: Atrial fibrillation (AF) is associated with increased risk of embolic stroke. Catheter ablation of AF provides an effective therapy for patients with symptomatic and drug‐refractory AF. The aim of this study was to evaluate whether the atrial electromechanical interval is useful in identifying patients at risk of stroke after successful catheter ablation. Methods and Results: A total of 279 AF patients who received catheter ablation and showed no evidence of recurrences were enrolled. Electromechanical interval (PA–PDI) was determined as the time interval from the initiation of P wave deflection to the peak of mitral inflow A wave on pulse wave Doppler imaging. The PA–PDI interval was measured for each patient after the 3‐month blanking period of catheter ablation. The clinical endpoint was the occurrence of ischemic stroke. During the follow‐up of 46.5 ± 17.2 months, 6 patients suffered from ischemic strokes. Patients with strokes had higher CHA₂DS₂–VASc scores and longer PA–PDI intervals (138.7 ± 12.4 ms vs 161.2 ± 7.7 ms, P value < 0.001) compared to those without strokes. At a cutoff point of 150 ms identified by ROC curve, the positive and negative predictive values of the PA–PDI interval to predict stroke were 86.7% and 100%, respectively. The PA–PDI interval improved the predictive performance of the CHA₂DS₂–VASc score, and the area under the ROC curve increased from 0.75 to 0.85. Conclusions: Our results suggest that the PA–PDI interval is a useful tool to identify patients with high risk of stroke after successful catheter ablation of AF. (J Cardiovasc Electrophysiol, Vol. 24, pp. 375‐380, April 2013)     

Clinical and Electrocardiographic Variables Can Predict Atrial Fibrillation in Patients with Atrioventricular Accessory Pathways

Background: Risk stratification of sudden death in patients with Wolff-Parkinson-White syndrome is based on the refractory period of the atrioventricular accessory pathway and the probability of spontaneous atrial fibrillation. Risk stratification based on invasive studies does not seem cost-effective in the radiofrequency ablation era, and, although sensitive, noninvasive tests are not used because of their low specificity. We sought to determine whether clinical and electrocardiographic variables can predict spontaneous atrial fibrillation in patients with an accessory pathway. Methods: We studied 420 consecutive patients treated by radiofrequency catheter ablation who had a single atrioventricular accessory pathway and the Influence of four variables: age, gender, location of the accessory pathway as determined by the site of successful radiofrequency ablation, and the presence of a manifest accessory pathway in the ECG was analyzed by multiple logistic regression analysis and a chi-square test. The development model, comprised of data from the first 359 patients, included 58 patients with spontaneous atrial fibrillation and 301 patients without spontaneous atrial fibrillation during follow-up. The likelihood ratio derived from the development model was validated in the last 61 patients. Results: Patients with spontaneous atrial fibrillation occurring before accessory pathway ablation were more often male and were older than those without atrial fibrillation. Atrial fibrillation occurred more frequently in manifest than in concealed accessory pathways, and the presence of posteroseptal accessory pathway strongly correlated with spontaneous atrial fibrillation. Conclusion: The probability of spontaneous atrial fibrillation was higher in men with a manifest posteroseptal accessory pathway and increased with age. A.N.E. 2000;5(1):45–52     

Torsades de Pointes as a Cause of Sudden Death in a Patient with Aortic Stenosis and Atrial Fibrillation

The occurrence of sudden cardiac death during Holter monitoring in patients with aortic stenosis has been reported previously. In the majority of the reported cases, the cause of death was a malignant ventricular tachyarrhythmia. The presence of a strong association between frequency and complexity of ventricular arrhythmias and sudden death in patients with aortic stenosis has been proposed. We report the case of a 77‐year‐old woman with aortic stenosis and atrial fibrillation who had an episode of torsades de pointes that degenerated into ventricular fibrillation during Holter monitoring. A short–long–short sequence, but not increased ventricular ectopics, precipitated torsades de pointes and sudden death in this case which is strongly indicative of triggered activity as the underlying mechanism of the lethal arrhythmia.     

Shorter Minimum P-Wave Duration Is Associated with Paroxysmal Lone Atrial Fibrillation

Background and Purpose

Prolonged P-wave dispersion (PWD) and P-wave duration (PWdur) have been found to be associated with common atrial fibrillation (AF), but the association of P-wave indices with lone atrial fibrillation (LAF) is unclear.

Methods

We enrolled 61 paroxysmal LAF cases and 150 controls without AF. P-wave indices were measured from a 12-lead ECG. Multivariable logistic regression was used to assess the association between P-wave indices and LAF.

Results

PWD was longer in LAF patients (median, IQR; 54.1 [42.9–63.2] ms) than controls (46.0 [38.5–57.7] ms), P = 0.03. MinPWdur was shorter in LAF patients (60.5 [50.7–72.6] ms) than controls (66.0 [55.5–76.4] ms), P = 0.03. In multivariable models, only the association between shorter minPWdur and LAF remained statistically significant (OR [95% CI] per tertile increment in minPWdur, 0.64 [0.42–0.95], P = 0.03).

Conclusions

Unlike common AF, paroxysmal LAF is independently associated with shorter minPWdur. This finding suggests that both shorter and prolonged PWdur may be associated with increased risk of AF.     

A Prospective Study of Atrial Fibrillation After Cardiac Surgery

Background: Atrial fibrillation (AF) is a commonly encountered arrhythmia following cardiac surgery and when sustained, may be associated with significant morbidity. Methods: This large prospective investigation examined a variety of clinical and P wave signal-averaged electrocardiogram (SAECG) parameters to identify independent predictors of AF following cardiac surgery. A total of 272 patients underwent P wave SAECG recording and analysis prior to surgery. Information on their clinical, surgical, and hemodynamic characteristics as well as hospital course was collected. Patients were followed during their postoperative course with telemetry and ECGs. Results: During an observation period of up to 14 days, 79 patients (29%) developed AF 2.5 ± 1.9 days after surgery. Patients who developed AF following cardiac surgery were more likely to be older, undergo valve surgery, to have ejection fraction (EF) < 40%, to have P wave duration on SAECG >140 ms (all P < 0.01), and to take digoxin preoperatively (P < 0.05). A multivariate analysis found that only P wave duration on SAECG >140 ms and EF < 40% were independent predictors of AF following cardiac surgery. The odds ratio of P wave duration on SAECG >140 ms and EF < 40% for the development of AF following cardiac surgery was 3.1 and 2.8, respectively, and 8.7 when combined. Conclusions: Thus, the presence of preexisting abnormal atrial substrate as detected by P wave prolongation on SAECG, and implicated by EF < 40%, clearly predicted a higher risk of AF following cardiac surgery and may provide clinicians with an effective means of identifying those at greatest risk.     

Atrial Appendage Thrombosis Risk Is Lower for Atrial Flutter Compared with Atrial Fibrillation

Background

The risk of stroke and thromboembolism in atrial fibrillation is established. However, the evidence surrounding the risk of thromboembolism in patients with atrial flutter is not as clear. We hypothesized that atrial flutter would have indicators of less risk for thromboembolism compared with atrial fibrillation on transesophageal echocardiography, thereby possibly leading to a lower stroke risk.

Maintenance of Sinus Rhythm after Cardioversion of Atrial Fibrillation in Patients with Lone Atrial Fibrillation and Patients with Hypertension

Background: The success rate and prognosis of cardioversion of atrial fibrillation (AF) in patients with organic heart disease is well known. In contrast, little data exist about cardioversion success and maintenance of sinus rhythm (SR) in patients with lone AF and in patients with hypertension as the only underlying cardiovascular disease. Methods: In a prospective cardioversion registry 148 of 181 patients (81.8%) with lone AF (age 58 ± 13 years, duration of AF 7.6 ± 19 weeks) and 120 of 148 patients (81.1%) with hypertension (age 62 ± 10 years, duration of AF 6.6 ± 21 weeks) had successful cardioversion and were followed for 7.7 ± 1.9 months. Results: At follow-up, 120 patients (81.1%) with lone AF were in SR, and 18 of these patients had had repeated cardioversion during follow-up (AF total recurrence rate 31.1%). In stepwise regression analysis, the number of previous cardioversions was predictive of rhythm at follow-up (P = 0.0453). Rhythm at follow-up did not differ between patients who were or were not on antiarrhythmic drugs. At follow-up 96 patients (80%) with hypertension were in SR, and 9 of these had had repeated cardioversion during follow-up (AF total recurrence rate 27.5%). As in lone AF, the recurrence rate of AF did not differ between patients with or without antiarrhythmic drug treatment, and in multivariate regression analysis, the number of previous cardioversions was the only clinical predictor of rhythm at follow-up (P = 0.0284). Conclusions: Even in patients with such benign conditions as lone AF or hypertension as the only underlying disease, the prognosis of cardioversion in terms of maintenance of SR is poor. Future studies of rhythm control versus rate control need to include not only patients with organic heart disease but also patients with lone AF and patients with hypertension, since the long-term benefits of these two strategies remain unclear even in these subsets of patients.     

Factor V Leiden and Risk of Ischemic Stroke in Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Background: Atrial fibrillation is a major cause of cardioembolic stroke. Since atrial and venous pressures are similar, genetic variants that promote venous thromboembolism may increase the risk of atrial thrombi and subsequent stroke in atrial fibrillation. Methods: We conducted a nested case-control study of the association between the presence of factor V Leiden polymorphism and incident ischemic stroke within a prospective cohort of 13,559 adult patients with diagnosed nonvalvular atrial fibrillation between July 1, 1996 and December 31, 1997. Incident cases with ischemic strokes were identified through August 31, 1999 and matching stroke-free controls were enrolled. Results: One hundred thirty-seven case patients with incident stroke and 214 controls were enrolled. Cases were older, more likely to be women, and more likely to have a prior stroke, heart failure, hypertension, diabetes, and coronary disease. The factor V Leiden polymorphism was present in 5.8% of cases and 3.7% of controls (P = 0.36). Among non-anticoagulated patients, 7/96 (7.3%) case patients and 3/81 (3.6%) control subjects were heterozygous for factor V Leiden (Odds Ratio 2.1 [95% CI: 0.5–8.4]). Adjustment for known stroke risk factors did not significantly change the observed association in non-anticoagulated patients (adjusted OR 1.9 [0.5–8.0]). Conclusions: Within a large nested case-control sample of patients with atrial fibrillation, factor V Leiden was not significantly associated with risk of stroke. However, given the suggestive nature of our findings, further study in even larger numbers of patients is needed to clarify the impact of factor V Leiden on stroke risk in atrial fibrillation.